Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
145 participants
INTERVENTIONAL
1994-12-31
2002-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Incentives to Increase Exercise in Cocaine Dependent Women
NCT01283191
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
NCT02143063
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208
CBT With Disulfiram and Contingency Management
NCT00350870
Effectiveness of Extended Treatments for Drug Dependence
NCT00685659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRA + CM
Community Reinforcement Approach (CRA) combined with Contingency Management (CM)
Behavioral therapy
TSF + CM
Twelve-Step Facilitation (TSF) combined with Contingency Management (CM)
Behavioral therapy
CRA + VC
Community Reinforcement Approach (CRA) combined with Voucher Control (VC)
Behavioral therapy
TSF + VC
Twelve-Step Facilitation (TSF) combined with Voucher Control (VC)
Behavioral therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women meeting DSM IV criteria for cocaine dependence with custody of a young child
Exclusion Criteria
* Psychosis
* Severe depression
* Current treatment with any anti-depressant or anti-psychotic medication
* Medical instability
* Inability to understand or read English
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yale University School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard S. Schottenfeld, M.D.
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The APT Foundation, Inc. MRU
New Haven, Connecticut, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9410007875
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.